Meeting: 2017 ASCO Annual Meeting Track: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy Abstract number: 507 Citation: J Clin Oncol 35, 2017 (suppl; abstr 507) Authors: Mette S. Van Ramshorst, Erik van Werkhoven, Ingrid A. Mandjes, et al. Background: Neoadjuvant chemotherapy with dual HER2 blockade boosts pathologic complete response (pCR) rates in HER2+ breast...
Pro zobrazení tohoto obsahu je třeba být přihlášen.